Article
Atypical hemolytic uremic syndrome
7 Jul 2010
Abstract excerpt
PURPOSE OF REVIEW: The last few years revealed a molecular distinction between thrombotic thrombocytopenic purpura, a disease characterized by a lack of ADAMTS13 activity, and atypical hemolytic uremic syndrome (aHUS), a disease of complement overactivation. Many different predisposing genetic factors resulting in complement overactivation have been described in aHUS. Additionally, autoantibodies against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
